Methods and systems for cryptographically secured outputs from telemedicine sessions

1. A system for cryptographically secured outputs from telemedicine sessions, the system comprising a computing device at a first location, the computing device configured to:

initiate a secure communication interface between the computing device and a client device associated with a human subject and at a second location;

receive, from at least a remote sensor at the second location, a plurality of current biological data associated with the human subject;

input, using the secure communication interface, an identifier of a biochemical element;

determine, as a function of the plurality of current biological data, a tolerability of the biochemical element;

generate a digitally signed authorization datum as a function of the determination;

generate at least a biometric identification signature of the human subject, wherein generating further comprises:

receiving subject signature training data, including a plurality of category descriptors and correlated biological data entries;

training a biometric signature model as a function of the subject signature training data and a machine-learning process; and

generating the biometric identification signature as a function of the biometric signature model;

determine a degree of similarity between the current biological data and the at least a biometric signature; and

authenticate the current biological data as a function of the degree of similarity such that a telemedicine session is secured based upon the current biological data associated with the human subject.

2. The system of claim 1 , wherein the computing device is further configured to input the identifier of the biochemical element by:

identifying a plurality of biochemical elements as a function of the plurality of current biological data;

transmitting the plurality of biochemical elements to the secure communication interface; and

receiving a command identifying the biochemical element as a function of the plurality of biochemical elements.

3. The system of claim 2 , wherein identifying the plurality of biochemical elements further comprises:

receiving biochemical training data correlating biological data elements to biochemical data elements;

training a biochemical classifier as a function of the biochemical training data; and

identifying the plurality of biochemical elements as a function of the biochemical classifier and the plurality of current biological data.

4. The system of claim 1 , wherein the computing device is configured to determine the tolerability of the biochemical element by:

retrieving stored biological data as a function of current biological data; and

determining the tolerability of the biochemical element as a function of the stored biological data.

5. The system of claim 1 , wherein the digitally signed authorization datum includes a timestamp indicating a time of initiation.

6. The system of claim 1 , wherein the digitally signed authorization datum includes an expiration period.

7. The system of claim 1 , wherein the computing device is further configured to post the digitally signed authorization datum to a distributed data structure.

8. The system of claim 1 , wherein the computing device is further configured to transmit the authorization datum identifier to client device.

9. A method of cryptographically secured outputs from telemedicine sessions, the method comprising:

initiating, by a computing device at a first location, a secure communication interface between the computing device and a client device associated with a human subject and at a second location;

receiving, by the computing device and from at least a remote sensor at the second location, a plurality of current biological data associated with the human subject;

inputting, by the computing device and using the secure communication interface, an identifier of a biochemical element;

determining, by the computing device and as a function of the plurality of current biological data, a tolerability of the biochemical element;

generating a digitally signed authorization datum as a function of the determination;

generating at least a biometric identification signature of the human subject, wherein generating further comprises:

receiving subject signature training data, including a plurality of category descriptors and correlated biological data entries;

training a biometric signature model as a function of the subject signature training data and a machine-learning process; and

generating the biometric identification signature as a function of the biometric signature model;

determining a degree of similarity between the current biological data and the at least a biometric signature; and

authenticating the current biological data as a function of the degree of similarity such that a telemedicine session is secured based upon the current biological data associated with the human subject.

10. The method of claim 9 , wherein inputting the identifier of the biochemical element further comprises:

identifying a plurality of biochemical elements as a function of the plurality of current biological data;

displaying the plurality of biochemical elements to a user of computing device; and

receiving a command from a user of the computing device selecting a biochemical element of the plurality of biochemical elements.

11. The method of claim 10 , wherein identifying the plurality of biochemical elements further comprises:

receiving biochemical training data correlating biological data elements to biochemical data elements;

training a biochemical classifier as a function of the biochemical training data; and

identifying the plurality of biochemical elements as a function of the biochemical classifier.

12. The method of claim 9 , wherein determining the tolerability of the biochemical element further comprises:

retrieving stored biological data as a function of current biological data; and

determining the tolerability of the biochemical element as a function of the stored biological data.

13. The method of claim 9 , wherein the digitally signed authorization datum includes a timestamp indicating a time of initiation.

14. The method of claim 9 , wherein the digitally signed authorization datum includes an expiration period.

15. The method of claim 9 further comprising posting the digitally signed authorization datum to a distributed data structure.

16. The method of claim 9 further comprising transmitting the authorization datum identifier to client device.